Target class/target | Reagent (drug/chemical probe/antisense) | Disease area | Mechanism | References |
---|---|---|---|---|
Histone demethylase, KDM6 subfamily of demethylases | GSK-J4 | Inflammation, autoimmunity | Suppression of proinflammatory cytokine production, targeting of H3K27 demethylases | [31] |
BET bromodomains | I-BET | Sepsis, inflammation | Inhibition of BET bromodomain interactions, suppression of cytokine production | [84] |
BET bromodomains | JQ1 | Bone disease/multiple myeloma | Inhibition of BET bromodomain interactions, MYC targeting | [85] |
Histone deacetylase (class 1 and II HDACs) | HDAC inhibitors | Osteoarthritis, RA | Â | |
miRNA (for example, miR146a, miR155) | Antisense RNA technologies | Autoimmunity, RA | Â |